Skip to content
Clinical Trials – home

Spitalul De Psihiatrie Titan Dr. Constantin Gorgos

Research site

Romania Bulevardul Pictor Nicolae Grigorescu Nr 41 Sector 3, 030442 Bucharest, Romania

  • Non-small cell lung cancer · Squamous cell carcinoma
  • Adult patients

About Specializations

Spitalul De Psihiatrie Titan Dr. Constantin Gorgos in Bucharest, Romania specialises in clinical trials of conditions such as Non-small cell lung cancer, Squamous cell carcinoma, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms

At Spitalul De Psihiatrie Titan Dr. Constantin Gorgos in Bucharest, clinical research is focused on neoplasms, with studies centered on improving care for patients with cancer. The trials are aimed at evaluating new treatment approaches and comparing how well different therapies help control disease and prevent recurrence.

  • Lung cancer research, especially metastatic non-squamous NSCLC, is examining whether one PD-1 inhibitor strategy offers better treatment effectiveness than another when used with chemotherapy.
  • Locally advanced cutaneous squamous cell carcinoma studies are assessing pembrolizumab as an adjuvant treatment to help reduce the risk of cancer returning after surgery.

This small but focused research portfolio reflects interest in both advanced solid tumors and post-surgical cancer control, with an emphasis on comparing treatment benefit and strengthening outcomes for patients with difficult-to-treat malignancies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Bulevardul Pictor Nicolae Grigorescu Nr 41 Sector 3030442 BucharestRomania
Recruiting now
no trials
Conditions studied
2

More sites in BucharestRomania

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study Comparing Dostarlimab and Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Glaxosmithkline Research & Development Limited

Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.